Frontier Space Technologies secures £131k for orbital microgravity labs

Manufacturing and biotechnology research in orbit is the focus of Frontier Space Technologies, which develops and operates microgravity platforms. The company hardware includes an autonomous lab-in-a-box and an in-space bioreactor, which allow life-science researchers to conduct protein crystallisation, cell culture, and antibody development. These services provide space-based capabilities for biotech companies requiring specialised environments for preclinical drug testing.

Based in Nottingham, the business was incorporated in 2021. A recent funding round raised an estimated £131k, resulting in an estimated post-money valuation of £930.1k.

According to accounts for the year ended 31 March 2025, the firm employed 9 people. The capital supports work in the manufacture of air and spacecraft and related machinery. The allotment of shares for this funding took place in April, with formal documentation filed in May.